FDAFDA · Food and drugs·Recall number D-0896-2023
PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10,
Published July 19, 2023 · Recall initiated: June 23, 2023
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specifications
What to do
Voluntary: Firm initiated
Recall details
- Brand
- PANCREAZE
- Manufacturer
- Vivus, Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0362541402102
- Lot
- Lot #: 102101, Exp: 31 July 2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.